The chemistry of platinum(II) and platinum(IV) with the ligands 3,4,5-tris(2-pyridyl)-4-H-1,2,4-triazole, L1, and 3,5-di(2-pyridyl)-4-(4-pyridyl)-4-H-1,2,4-triazole, L2, is described. The ligand L1 forms platinum(II) complexes [PtXY(κ 2 -N, N′-L1)] (X, Y = Cl, Cl; Cl, Me; Me, Me) by chelation while ligand L2 forms either analogous chelate complexes [PtXY(κ 2 - N, N′-L2)] (X, Y = Cl, Me; Me, Me) or acts as a monodentate ligand in forming trans-[PtCl 2 (SMe 2 )(κ 1 -N-L2)], in which only the 4-pyridyl group is coordinated. The electron-rich dimethylplatinum(II) complexes undergo oxidative addition reactions with methyl iodide to give [PtIMe 3 (κ 2 -N, N′-L1)], or with dichloromethane to give [PtClMe 2 (CH 2 Cl)(κ 2 -N, N′-L1)] or [PtClMe 2 (CH 2 Cl)(κ 2 -N, N′-L2)], each of which is formed as a mixture of three isomers. Structure determinations of several of these complexes are reported.
No takes yet. Share an insight, caveat, or question.
Abo-Amer et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: